Aspirin Colorectal Adenoma Risk Significantly Reduced, NEJM Studies Find
This article was originally published in The Tan Sheet
Executive Summary
Daily aspirin therapy reduces the incidence of recurrent adenomas among colorectal cancer survivors and individuals with a history of adenomas, according to two separate studies in the March 6 New England Journal of Medicine
You may also be interested in...
Long-Term Aspirin Use Reduces Colorectal Cancer Risk – Nurses’ Health Study
Women who took more than 14 aspirin per week for 10 years or more demonstrated a 33% lower risk for colorectal cancer compared to nonusers, according to a study published in the Aug. 24-31 Journal of the American Medical Association
Long-Term Aspirin Use Reduces Colorectal Cancer Risk – Nurses’ Health Study
Women who took more than 14 aspirin per week for 10 years or more demonstrated a 33% lower risk for colorectal cancer compared to nonusers, according to a study published in the Aug. 24-31 Journal of the American Medical Association
Long-Term Aspirin Use Reduces Colorectal Cancer Risk – Nurses’ Health Study
Women who took more than 14 aspirin per week for 10 years or more demonstrated a 33% lower risk for colorectal cancer compared to nonusers, according to a study published in the Aug. 24-31 Journal of the American Medical Association